Ambey Laboratories Past Earnings Performance
Past criteria checks 1/6
Ambey Laboratories has been growing earnings at an average annual rate of 10.1%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 13.2% per year. Ambey Laboratories's return on equity is 6.3%, and it has net margins of 3.6%.
Key information
10.1%
Earnings growth rate
-22.6%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 13.2% |
| Return on equity | 6.3% |
| Net Margin | 3.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Ambey Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,298 | 47 | 27 | 0 |
| 30 Jun 24 | 1,259 | 62 | 27 | 0 |
| 31 Mar 24 | 1,219 | 77 | 28 | 0 |
| 31 Mar 23 | 1,075 | 52 | 36 | 0 |
| 31 Mar 22 | 849 | 36 | 30 | 0 |
| 31 Mar 21 | 821 | 103 | 28 | 0 |
| 31 Mar 20 | 670 | 2 | 52 | 0 |
Quality Earnings: AMBEY has a high level of non-cash earnings.
Growing Profit Margin: AMBEY's current net profit margins (3.6%) are lower than last year (5.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMBEY's earnings have grown by 10.1% per year over the past 5 years.
Accelerating Growth: AMBEY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMBEY had negative earnings growth (-27.3%) over the past year, making it difficult to compare to the Chemicals industry average (8%).
Return on Equity
High ROE: AMBEY's Return on Equity (6.3%) is considered low.